A
AptaBio Therapeutics Inc
KOSDAQ:293780
AptaBio Therapeutics Inc
KOSDAQ:293780
Price:
7 850
KRW
-1.01%
Market Closed
Market Cap:
₩220.5B
Balance Sheet
Balance Sheet Decomposition
AptaBio Therapeutics Inc
AptaBio Therapeutics Inc
Balance Sheet Decomposition is not available for
AptaBio Therapeutics Inc
AptaBio Therapeutics Inc
Balance Sheet
AptaBio Therapeutics Inc
AptaBio Therapeutics Inc
Currency: KRW
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
2 808
|
4 311
|
16 602
|
14 686
|
6 566
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
2 808
|
4 311
|
16 602
|
14 686
|
6 566
|
|
| Short-Term Investments |
7 763
|
15 383
|
29 556
|
28 139
|
16 344
|
|
| Total Receivables |
25
|
166
|
323
|
680
|
479
|
|
| Accounts Receivables |
1
|
112
|
323
|
326
|
157
|
|
| Other Receivables |
24
|
54
|
0
|
354
|
322
|
|
| Other Current Assets |
60
|
87
|
286
|
240
|
387
|
|
| Total Current Assets |
10 656
|
19 946
|
46 767
|
43 745
|
23 777
|
|
| PP&E Net |
275
|
287
|
4 033
|
4 889
|
4 822
|
|
| PP&E Gross |
275
|
287
|
4 033
|
4 889
|
4 822
|
|
| Accumulated Depreciation |
21
|
30
|
102
|
317
|
583
|
|
| Intangible Assets |
2
|
8
|
13
|
47
|
42
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
53
|
67
|
26 559
|
26 598
|
36 205
|
|
| Other Long-Term Assets |
16
|
20
|
32
|
165
|
65
|
|
| Total Assets |
11 002
N/A
|
20 328
+85%
|
77 404
+281%
|
75 444
-3%
|
64 911
-14%
|
|
| Liabilities | ||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
47
|
167
|
208
|
379
|
404
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2 202
|
0
|
25
|
26
|
55
|
|
| Other Current Liabilities |
20 690
|
1 009
|
498
|
396
|
329
|
|
| Total Current Liabilities |
22 939
|
1 176
|
731
|
801
|
788
|
|
| Long-Term Debt |
4 818
|
0
|
61
|
35
|
47
|
|
| Other Liabilities |
14 783
|
841
|
1 457
|
2 567
|
2 411
|
|
| Total Liabilities |
42 540
N/A
|
2 017
-95%
|
2 249
+12%
|
3 403
+51%
|
3 246
-5%
|
|
| Equity | ||||||
| Common Stock |
226
|
4 334
|
5 441
|
5 548
|
11 098
|
|
| Retained Earnings |
31 864
|
36 013
|
42 694
|
47 576
|
58 203
|
|
| Additional Paid In Capital |
100
|
49 991
|
112 408
|
114 068
|
108 770
|
|
| Total Equity |
31 538
N/A
|
18 312
N/A
|
75 155
+310%
|
72 040
-4%
|
61 665
-14%
|
|
| Total Liabilities & Equity |
11 002
N/A
|
20 328
+85%
|
77 404
+281%
|
75 444
-3%
|
64 911
-14%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
5
|
9
|
11
|
11
|
22
|
|
Switch to:
Switch to:
See Also
Discover More
